Nilda Atienza-Isman
Family · Las Vegas, NVNPI 1780171041
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 61 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 22.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $594, 3.1 times the $193 reported in 2021.
Across 61 payments — averaging $27.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$369
- AbbVie$243
- AstraZeneca$234
- E.r. Squibb & Sons, L.L.C.$123
- Sanofi-aventis U.S. LLC$108
- Dexcom, Inc.$83
- plus $507 from 15 others
What the payments were for
- Food & beverage$1,666100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 9 | $369 |
| AbbVie | 9 | $243 |
| AstraZeneca | 8 | $234 |
| E.r. Squibb & Sons, L.L.C. | 5 | $123 |
| Sanofi-aventis U.S. LLC | 1 | $108 |
| Dexcom, Inc. | 5 | $83 |
| Abbott | 2 | $57 |
| Kowa Pharmaceuticals America, Inc. | 3 | $56 |
| Bayer | 2 | $48 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $45 |
| Johnson & Johnson | 2 | $44 |
| Lilly USA, LLC | 2 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| Lifescan, Inc. | 1 | $36 |
| Amgen | 1 | $30 |
| Medtronic | 1 | $25 |
| Shield Therapeutics Inc | 1 | $20 |
| Almatica Pharma LLC | 1 | $19 |
| Exact Sciences | 1 | $16 |
| Si-bone, Inc. | 1 | $15 |
| Scilex Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,666 in reported general payments places this provider in the 75th percentile of 1,501 family providers in Nevada.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 13 | $3,223 |
| Atorvastatin Calcium | 60 | $604 |
| Gabapentin | 13 | $438 |
| Metformin Hcl | 51 | $276 |
| Losartan Potassium | 31 | $198 |
| Levothyroxine Sodium | 22 | $197 |
| Lovastatin | 16 | $147 |
| Lisinopril | 39 | $146 |
| Amlodipine Besylate | 28 | $86 |
| Glipizide | 18 | $61 |
| Metformin Hcl ErMetformin Hcl | 13 | $48 |
| Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide | 11 | $44 |
| Alendronate Sodium | 16 | $30 |
Paid to pharmacies, not to this prescriber.
Other family in Las Vegas
- Hollie TylerLas Vegas$118K
- John PhoenixLas Vegas$107K
- Jon FaillaLas Vegas$74K
- Alex LapasaranLas Vegas$50K
- Erin WilkinsonLas Vegas$43K
- Anna Melisa Lopez-SanglayLas Vegas$42K
- Kelly PapeshLas Vegas$28K
- Bernard BlanksLas Vegas$26K
- Hillary DursteinLas Vegas$21K
- Victoria HughesLas Vegas$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.